Aj. Orsini et al., ROUTINE USE OF FENTANYL INFUSIONS FOR PAIN AND STRESS REDUCTION IN INFANTS WITH RESPIRATORY-DISTRESS SYNDROME, The Journal of pediatrics, 129(1), 1996, pp. 140-145
Objective: To determine whether fentanyl infusions given to premature
infants with respiratory distress syndrome reduce stress and improve l
ong- and short-term outcome, Methods: Twenty premature infants undergo
ing mechanical ventilation for respiratory distress syndrome were rand
omly assigned, in a double-blind fashion, to receive fentanyl by conti
nuous infusion or a volume-matched placebo infusion, A behavioral stat
e score was used to assess the infants' behavior, Cortisol and 11-deox
ycortisol levels were measured as physiologic markers of stress, Urina
ry 3-methyl histidine/creatinine molar ratio was determined and the fr
actional excretion of urea was measured to assess catabolic state, Ven
tilatory indexes were recorded for each infant, Results: Infants recei
ving fentanyl showed significantly lower behavioral state scores (p <
0.04) and lower heart rates (p < 0.001) than those receiving placebo,
11-Deoxycortisol levels were lower in the fentanyl group on days 3, 4,
and 5 of the study (p < 0.003). 3-Methyl histidine/creatinine ratios
and fractional excretion of urea were not significantly different betw
een the two groups, On the third day of the study, infants receiving f
entanyl required a higher ventilator rate (p < 0.01), higher peak insp
iratory pressures (p < 0.001), and higher positive end-expiratory pres
sure (p < 0.0001) than those receiving placebo, There was no differenc
e in long-term outcome with respect to the incidence of bronchopulmona
ry dysplasia, intraventricular hemorrhage, or sepsis or with respect t
o the duration of ventilator use, Conclusions: Although there was a re
duction in stress markers in the infants receiving fentanyl, we were u
nable to demonstrate an improvement in catabolic state or long-term ou
tcome, In addition, the infants receiving fentanyl required higher ven
tilatory support in the early phase of respiratory distress syndrome t
han did those receiving placebo.